Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1985 1
1986 1
1994 1
1996 1
1997 1
1999 2
2001 1
2002 1
2004 1
2006 1
2008 1
2009 1
2011 1
2012 3
2013 2
2014 3
2015 3
2018 1
2019 1
2020 2
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Lip Squamous Cell Carcinoma"
Page 1
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. Cohen EEW, et al. J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. J Immunother Cancer. 2019. PMID: 31307547 Free PMC article. Clinical Trial.
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths in the United States …
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharyn …
Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC, de Carpentier J, Hopper C, Leonard AG, Putnam G. Kübler AC, et al. Int J Oral Maxillofac Surg. 2001 Dec;30(6):504-9. doi: 10.1054/ijom.2001.0160. Int J Oral Maxillofac Surg. 2001. PMID: 11829232 Clinical Trial.
Carcinoma of the lip is a common cancer of the head and neck area; its incidence is approximately one-quarter that for oral cavity cancers. ...Twenty-five patients with squamous cell carcinoma (SCC) of the lip (Tis, T1, T2/N0/M0) and Karn …
Carcinoma of the lip is a common cancer of the head and neck area; its incidence is approximately one-quarter that for oral ca …
Cervical lymph node metastases and T1 squamous cell carcinoma of the lips.
Bon-Mardion N, De Raucourt D, Babin E, Rame JP, Dehesdin D, Choussy O. Bon-Mardion N, et al. B-ENT. 2015;11(2):89-93. B-ENT. 2015. PMID: 26563007
OBJECTIVE: The occurrence of cervical lymph node metastasis is a major prognostic factor for head and neck squamous cell carcinoma (SCC) of the lip. This study focuses on patients with T1 stage tumours,in order to describe the prevalence of metastat …
OBJECTIVE: The occurrence of cervical lymph node metastasis is a major prognostic factor for head and neck squamous cell ca …
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study.
Powell SF, Gold KA, Gitau MM, Sumey CJ, Lohr MM, McGraw SC, Nowak RK, Jensen AW, Blanchard MJ, Fischer CD, Bykowski J, Ellison CA, Black LJ, Thompson PA, Callejas-Valera JL, Lee JH, Cohen EEW, Spanos WC. Powell SF, et al. J Clin Oncol. 2020 Jul 20;38(21):2427-2437. doi: 10.1200/JCO.19.03156. Epub 2020 Jun 1. J Clin Oncol. 2020. PMID: 32479189 Free PMC article. Clinical Trial.
PURPOSE: Pembrolizumab is a humanized monoclonal antibody that blocks interaction between programmed death receptor-1 (PD-1) and its ligands (PD-L1, PD-L2). Although pembrolizumab is approved for recurrent/metastatic head and neck squamous cell carcinoma …
PURPOSE: Pembrolizumab is a humanized monoclonal antibody that blocks interaction between programmed death receptor-1 (PD-1) and its ligands …
Carcinoma of the lip.
Wurman LH, Adams GL, Meyerhoff WL. Wurman LH, et al. Am J Surg. 1975 Oct;130(4):470-4. doi: 10.1016/0002-9610(75)90486-9. Am J Surg. 1975. PMID: 1101725 Review.
A retrospective analysis of 206 patients with lip cancer is presented. Poorly differentiated primary lesions have a high rate of metastases. The metastatic potential of well differentiated lesions, when classified by size in the TNM staging system, is the same as th …
A retrospective analysis of 206 patients with lip cancer is presented. Poorly differentiated primary lesions have a high rate of meta …
Lung squamous carcinoma involving the lip and cheek.
Yan B, Wu F, Yang N, Zhang Y. Yan B, et al. Lancet Oncol. 2018 Dec;19(12):e726. doi: 10.1016/S1470-2045(18)30441-8. Lancet Oncol. 2018. PMID: 30507439 No abstract available.
High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T, Matsuzaki H, Takemoto M, Katsui K, Hara M, Katayama N, Waki T, Kanazawa S, Asaumi J. Unetsubo T, et al. Radiat Oncol. 2015 Apr 8;10:81. doi: 10.1186/s13014-015-0390-z. Radiat Oncol. 2015. PMID: 25888772 Free PMC article.
BACKGROUND: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity cancer. However, limited reports exist regarding the feasibility of this method. In this retrospective study, we evaluated the outcome of this …
BACKGROUND: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity ca …
Results of radiotherapy for squamous cell carcinoma of the vermilion border of the lower lip. A retrospective analysis of 108 patients.
de Visscher JG, Grond AJ, Botke G, van der Waal I. de Visscher JG, et al. Radiother Oncol. 1996 Apr;39(1):9-14. doi: 10.1016/0167-8140(96)01716-1. Radiother Oncol. 1996. PMID: 8735488
The authors analyzed the clinical history, tumor histology and stage, and outcome of a group of 108 patients with squamous cell carcinoma (SCC) of the vermilion border of the lower lip who underwent radiation therapy in the period between 1980 a …
The authors analyzed the clinical history, tumor histology and stage, and outcome of a group of 108 patients with squamous …
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.
Arnold SM, Moon J, Williamson SK, Atkins JN, Ou SH, LeBlanc M, Urba SG. Arnold SM, et al. Invest New Drugs. 2011 Apr;29(2):352-9. doi: 10.1007/s10637-009-9348-z. Epub 2009 Nov 25. Invest New Drugs. 2011. PMID: 19937365 Free PMC article. Clinical Trial.
PURPOSE: Eribulin mesylate, an halichondrin B analog, binds to tubulin and microtubules and possesses broad anti-cancer activity. We conducted a multi-institutional Phase II trial to evaluate the response rate of eribulin mesylate in patients with metastatic or recu …
PURPOSE: Eribulin mesylate, an halichondrin B analog, binds to tubulin and microtubules and possesses broad anti-cancer activity. We conduct …
A clinical study on survival rate of patients with squamous cell carcinoma of the lower lip in Kosovo.
Salihu S, Güven O, Gllareva E, Prekazi M, Salihu L. Salihu S, et al. J Craniomaxillofac Surg. 2014 Dec;42(8):1773-7. doi: 10.1016/j.jcms.2014.06.013. Epub 2014 Jun 24. J Craniomaxillofac Surg. 2014. PMID: 25183172
OBJECTIVE: The aim of this study is to find out the survival rate of patients with squamous cell carcinoma of the lower lip in Kosovo and to see the effect of stage of disease on the success of surgical treatment. PATIENTS AND METHODS: 789 patients wit …
OBJECTIVE: The aim of this study is to find out the survival rate of patients with squamous cell carcinoma of the lower …
30 results